Search results for interferon production:
A new mechanism regulates type I interferon production in white blood cells
Jan 12, 2009 |
not rated yet |
0
A study from a team of researchers led by Dr. Andrew P. Makrigiannis, Director of the Molecular Immunology Research Unit at the IRCM, has identified a new mechanism regulating interferon production. This discovery, co-authored ...
Genetic breakthrough supercharges immunity to flu and other viruses
Feb 13, 2008 |
4.8 / 5 (30) |
0
Researchers at McGill University have discovered a way to boost an organism’s natural anti-virus defences, effectively making its cells immune to influenza and other viruses.
Papillomavirus silences innate immune response
17 hours ago |
not rated yet |
0
In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to degenerate. ...
Researchers prolong the half-life of biopharmaceutical proteins
Sep 18, 2009 |
not rated yet |
0
Many biopharmaceuticals comprise small proteins that are quickly eliminated from the body. Scientists at the Technische Universitaet Muenchen (Germany) combine such small proteins with a kind of molecular ...
Interferon could be a key to preventing or treating multiple sclerosis
Oct 30, 2008 |
4 / 5 (3) |
0
Multiple sclerosis (MS) results when the body's own defense system attacks nerve fibers in the brain and spinal cord. Now scientists led by John Russell, Ph.D., at Washington University School of Medicine in St. Louis have ...
The right messenger for a healthy immune response
Jul 20, 2009 |
5 / 5 (1) |
0
Researchers from the Molecular Immunology group at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany have now shown that Beta-Interferon also plays a crucial role during an immune response: without ...
Adding steroid drug to MS treatment may reduce disease activity
Apr 30, 2009 |
5 / 5 (2) |
0
Using a steroid drug for multiple sclerosis (MS) in addition to an MS drug may reduce the amount of disease activity more than using the MS drug alone, according to a study that will be presented as part of the Late-breaking ...
Scientists shine new light on inflammatory diseases
Mar 16, 2008 |
4.3 / 5 (3) |
0
Investigators at Hospital for Special Surgery have identified a new mechanism involved in the pathogenesis of inflammatory diseases such as rheumatoid arthritis. The mechanism may also shed some light on why gene therapy ...
Gamma interferon could aid fight against fungal infections
Biology /
Oct 31, 2007 |
4.3 / 5 (3) |
0
Interferon, the “superhero” cure for viral infections, may be a strong weapon in the battle against fungal infections in immunocompromised patients, according to an article in the November issue of Microbiology Today.
Interferon needed for cells to 'remember' how to defeat a virus
Dec 03, 2008 |
5 / 5 (1) |
0
Scientists at UT Southwestern Medical Center have determined that the immune-system protein interferon plays a key role in "teaching" the immune system how to fight off repeated infections of the same virus.
New discovery gives tuberculosis vaccine a shot in the arm
Biology /
Feb 26, 2009 |
4.5 / 5 (2) |
0
A new article appearing in the March 2009 issue of the Journal of Leukocyte Biology may lead to improvements in the efficacy of the current tuberculosis vaccine. Specifically, a team of Italian researchers discovered a new ...
Interferon as long-term treatment for hepatitis C not effective
Dec 04, 2008 |
4 / 5 (3) |
0
Use of the drug interferon as a long-term maintenance strategy to slow the progression of liver disease associated with the hepatitis C virus is ineffective, UT Southwestern Medical Center researchers and their colleagues ...
Tuberculosis patients can reduce transmissability by inhaling interferon through a nebulizer
Sep 15, 2009 |
not rated yet |
0
A new study published in the September 15, 2009, issue of PLoS ONE found that patients with cavitary pulmonary tuberculosis receiving anti-TB medications supplemented with nebulized interferon-gamma have fewer bacilli in the ...
Good news for some hard-to-treat hepatitis C patients
Jun 16, 2009 |
not rated yet |
0
In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to ...
Research team sheds light on immune system suppression
Biology /
Oct 17, 2008 |
4 / 5 (2) |
0
The work was reported in the October 16 issue of the journal Cell Host & Microbe. The study described the suppression of this immune response in mice infected with lymphocytic choriomeningitis virus, pointing to potential new av ...
